Enhanced recognition of HIV-1 cryptic epitopes restricted by HLA Class I alleles associated with a favorable clinical outcome

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 1, 2015, Pages 1-8

  Bansal, Anju ^a   Mann, Tiffanie ^a   Sterrett, Sarah ^a   Peng, Binghao J ^a   Bet, Anne ^a   Carlson, Jonathan M ^b   Goepfert, Paul A ^a  

^a University of Alabama at Birmingham   (United States)

^b MICROSOFT RESEARCH   (United States)

Author keywords

alternative reading frames; chronic HIV 1 infection; cryptic epitopes; HLA B57; protective alleles

Indexed keywords

CRYPTIC EPITOPE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA B 5501 ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA B5301 ANTIGEN; HLA B57 ANTIGEN; HLA B5801 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; FEMALE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; VIRUS LOAD; COHORT ANALYSIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MONONUCLEAR CELL; SECRETION (PROCESS); VIROLOGY;

ADULT; ALLELES; COHORT STUDIES; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84939782737     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000700     Document Type: Conference Paper

References (99)

1. Cohen J. AIDS research. More woes for struggling HIV vaccine field. Science. 2013; 340: 667
2. Haynes BF, Gilbert PB, McElrath MJ, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012; 366: 1275-1286
3. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009; 361: 2209-2220
4. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 1997; 3: 205-211
5. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997; 3: 212-217
6. Goulder PJ, Walker BD. The great escape-AIDS viruses and immune control. Nat Med. 1999; 5: 1233-1235
7. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med. 2004; 10: 282-289
8. Wei X, Decker JM, Wang S, et al. Antibody neutralization and escape by HIV-1. Nature. 2003; 422: 307-312
9. Barouch DH, Korber B. HIV-1 vaccine development after STEP. Annu Rev Med. 2010; 61: 153-167
10. Barouch DH, OBrien KL, Simmons NL, et al. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med. 2010; 16: 319-323
11. Kong WP, Wu L, Wallstrom TC, et al. Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination. J Virol. 2009; 83: 2201-2215
12. Picker LJ, Hansen SG, Lifson JD. New paradigms for HIV/AIDS vaccine development. Annu Rev Med. 2012; 63: 95-111
13. Santra S, Liao HX, Zhang R, et al. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med. 2010; 16: 324-328
14. Santra S, Muldoon M, Watson S, et al. Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens. Virology. 2012; 428: 121-127
15. Liu J, OBrien KL, Lynch DM, et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature. 2009; 457: 87-91
16. Wilson NA, Keele BF, Reed JS, et al. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol. 2009; 83: 6508-6521
17. Bruce AG, Atkins JF, Gesteland RF. tRNA anticodon replacement experiments show that ribosomal frameshifting can be caused by doublet decoding. Proc Natl Acad Sci U S A. 1986; 83: 5062-5066
18. Bullock TN, Patterson AE, Franlin LL, et al. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J Exp Med. 1997; 186: 1051-1058
19. Core LJ, Lis JT. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science. 2008; 319: 1791-1792
20. Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science. 2008; 322: 1845-1848
21. Dolan BP, Bennink JR, Yewdell JW. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci. 2011; 68: 1481-1489
22. Dolan BP, Li L, Veltri CA, et al. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J Immunol. 2011; 186: 2065-2072
23. He Y, Vogelstein B, Velculescu VE, et al. The antisense transcriptomes of human cells. Science. 2008; 322: 1855-1857
24. Malarkannan S, Horng T, Shih PP, et al. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity. 1999; 10: 681-690
25. Miller RH. Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand. Science. 1988; 239: 1420-1422
26. Morris KV, Santoso S, Turner AM, et al. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet. 2008; 4: e1000258
27. Saulquin X, Scotet E, Trautmann L, et al. +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. J Exp Med. 2002; 195: 353-358
28. Schwab SR, Shugart JA, Horng T, et al. Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol. 2004; 2: e366
29. Starck SR, Jiang V, Pavon-Eternod M, et al. Leucine-TRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science. 2012; 336: 1719-1723
30. Starck SR, Ow Y, Jiang V, et al A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One. 2008; 3: e3460
31. Starck SR, Shastri N. Non-conventional sources of peptides presented by MHC class I. Cell Mol Life Sci. 2011; 68: 1471-1479
32. Zook MB, Howard MT, Sinnathamby G, et al. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J Immunol. 2006; 176: 6928-6934
33. Bukrinsky MI, Etkin AF. Plus strand of the HIV provirus DNA is expressed at early stages of infection. AIDS Res Hum Retroviruses. 1990; 6: 425-426
34. Cavanagh MH, Landry S, Audet B, et al. HTLV-I antisense transcripts initiating in the 3LTR are alternatively spliced and polyadenylated. Retrovirology. 2006; 3: 15
35. Landry S, Halin M, Lefort S, et al. Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology. 2007; 4: 71
36. Larocque E, Halin M, Landry S, et al. Human T-cell lymphotropic virus type 3 (HTLV-3)-And HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization. J Virol. 2011; 85: 12673-12685
37. Laverdure S, Gross A, Arpin-Andre C, et al. HIV-1 antisense transcription is preferentially activated in primary monocyte-derived cells. J Virol. 2012; 86: 13785-13789
38. Lefebvre G, Desfarges S, Uyttebroeck F, et al. Analysis of HIV-1 expression level and sense of transcription by high-Throughput sequencing of the infected cell. J Virol. 2011; 85: 6205-6211
39. Bansal A, Carlson J, Yan J, et al. CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. J Exp Med. 2010; 207: 51-59
40. Berger CT, Carlson JM, Brumme CJ, et al. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J Exp Med. 2010; 207: 61-75
41. Bet A, Sterrett S, Sato A, et al. Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccine. J Acquir Immune Defic Syndr. 2014; 65: 142-150
42. Cardinaud S, Moris A, Fevrier M, et al. Identification of cryptic MHC Irestricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med. 2004; 199: 1053-1063
43. Cardinaud S, Starck SR, Chandra P, et al. The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS One. 2010; 5: e8692
44. Champiat S, Raposo RA, Maness NJ, et al. Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PLoS One. 2012; 7: e39311
45. Dolan BP, Li L, Takeda K, et al. Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase. J Immunol. 2010; 184: 1419-1424
46. Garrison KE, Champiat S, York VA, et al. Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol. 2009; 16: 1369-1371
47. Gaur A, Green WR. Role of a cytotoxic-T-lymphocyte epitope-defined, alternative gag open reading frame in the pathogenesis of a murine retrovirusinduced immunodeficiency syndrome. J Virol. 2005; 79: 4308-4315
48. Gnjatic S, Jager E, Chen WS, et al. CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Proc Natl Acad Sci U S A. 2002; 99: 11813-11818
49. Ho O, Green WR. Cytolytic CD8(+) T cells directed against a cryptic epitope derived from a retroviral alternative reading frame confer disease protection. J Immunol. 2006; 176: 2470-2475
50. Ho O, Green WR. Alternative translational products and cryptic T cell epitopes: expecting the unexpected. J Immunol. 2006; 177: 8283-8289
51. Li CW, Goudy K, Hirsch M, et al. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proc Natl Acad Sci U S A. 2009; 106: 10770-10774
52. Maness NJ, Valentine LE, May GE, et al. AIDS virus-specific CD8(+) T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med. 2007; 204: 2505-2512
53. Maness NJ, Walsh AD, Piaskowski SM, et al. CD8+ T cell recognition of cryptic epitopes is a ubiquitous feature of AIDS virus infection. J Virol. 2010; 84: 11569-11574
54. Maness NJ, Wilson NA, Reed JS, et al. Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope. J Immunol. 2010; 184: 67-72
55. Mayrand SM, Green WR. Non-Traditionally derived CTL epitopes: exceptions that prove the rules? Immunol Today. 1998; 19: 551-556
56. Probst-Kepper M, Stroobant V, Kridel R, et al. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J Exp Med. 2001; 193: 1189-1198
57. Ronsin C, Chung-Scott V, Poullion I, et al A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumorinfiltrating lymphocytes in situ. J Immunol. 1999; 163: 483-490
58. Shichijo S, Nakao M, Imai Y, et al A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J Exp Med. 1998; 187: 277-288
59. Wang RF, Johnston SL, Zeng G, et al A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J Immunol. 1998; 161: 3598-3606
60. Wang RF, Parkhurst MR, Kawakami Y, et al. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med. 1996; 183: 1131-1140
61. Weinzierl AO, Maurer D, Altenberend F, et al A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays. Cancer Res. 2008; 68: 2447-2454
62. Schirmbeck R, Riedl P, Fissolo N, et al. Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopes. J Immunol. 2005; 174: 4647-4656
63. Fissolo N, Riedl P, Reimann J, et al. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence. Eur J Immunol. 2005; 35: 117-127
64. Cardinaud S, Consiglieri G, Bouziat R, et al. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope. PLoS Pathog. 2011; 7: e1002049
65. Walsh AD, Bimber BN, Das A, et al. Acute phase CD8+ T lymphocytes against alternate reading frame epitopes select for rapid viral escape during SIV infection. PLoS One. 2013; 8: e61383
66. Bansal A, Yue L, Conway J, et al. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents. AIDS. 2007; 21: 2387-2397
67. Chen H, Ndhlovu ZM, Liu D, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol. 2012; 13: 691-700
68. Elahi S, Dinges WL, Lejarcegui N, et al. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med. 2011; 17: 989-995
69. Hendel H, Caillat-Zucman S, Lebuanec H, et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol. 1999; 162: 6942-6946
70. Jansen CA, Kostense S, Vandenberghe K, et al. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur J Immunol. 2005; 35: 150-158
71. Jin X, Gao X, Ramanathan M Jr, et al. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B35 genotypes. J Virol. 2002; 76: 12603-12610
72. Scherer A, Frater J, Oxenius A, et al. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci U S A. 2004; 101: 12266-12270
73. Streeck H, Lichterfeld M, Alter G, et al. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol. 2007; 81: 7725-7731
74. Xie J, Lu W, Samri A, et al. Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLAB57/5801 and virus control. AIDS. 2010; 24: 2323-2329
75. Heckerman D, Kadie C, Listgarten J. Leveraging information across HLA alleles/supertypes improves epitope prediction. J Comput Biol. 2007; 14: 736-746
76. Bansal A, Gough E, Sabbaj S, et al. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS. 2005; 19: 241-250
77. Akinsiku OT, Bansal A, Sabbaj S, et al. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression. J Acquir Immune Defic Syndr. 2011; 58: 132-140
78. Ludwig LB, Ambrus JL Jr, Krawczyk KA, et al. Human immunodeficiency virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology. 2006; 3: 80
79. Michael NL, Vahey MT, dArcy L, et al. Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol. 1994; 68: 979-987
80. Almeida CA, Bronke C, Roberts SG, et al. Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-Adapted variant epitopes. J Immunol. 2011; 187: 2502-2513
81. Carlson JM, Brumme CJ, Martin E, et al. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol. 2012; 86: 13202-13216
82. Serwanga J, Shafer LA, Pimego E, et al. Host HLA B allele-Associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naive Ugandans. PLoS One. 2009; 4: e4188
83. Vaidya SA, Streeck H, Beckwith N, et al. Temporal effect of HLA-B 7 on viral control during primary HIV-1 infection. Retrovirology. 2013; 10: 139
84. Juarez-Molina CI, Payne R, Soto-Nava M, et al. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados. J Virol. 2014; 88: 10392-10398
85. Salgado M, Simon A, Sanz-Minguela B, et al. An additive effect of protective host genetic factors correlates with HIV nonprogression status. J Acquir Immune Defic Syndr. 2011; 56: 300-305
86. Frater AJ, Brown H, Oxenius A, et al. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol. 2007; 81: 6742-6751
87. Goepfert PA, Lumm W, Farmer P, et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med. 2008; 205: 1009-1017
88. Edwards BH, Bansal A, Sabbaj S, et al. Magnitude of functional CD8+T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol. 2002; 76: 2298-2305
89. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007; 13: 46-53
90. Martinez-Picado J, Prado JG, Fry EE, et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol. 2006; 80: 3617-3623
91. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic Tlymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994; 68: 6103-6110
92. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009; 206: 1253-1272
93. Maness NJ, Sacha JB, Piaskowski SM, et al. Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopes. J Virol. 2009; 83: 10280-10285
94. Loffredo JT, Friedrich TC, Leon EJ, et al. CD8+ T cells from SIV elite controller macaques recognize Mamu-B.08-bound epitopes and select for widespread viral variation. PLoS One. 2007; 2: e1152
95. Mudd PA, Martins MA, Ericsen AJ, et al. Vaccine-induced CD8+ T cells control AIDS virus replication. Nature. 2012; 491: 129-133
96. OConnor DH, Mothe BR, Weinfurter JT, et al. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acutephase cytotoxic-T-lymphocyte responses. J Virol. 2003; 77: 9029-9040
97. Sacha JB, Buechler MB, Newman LP, et al. Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr-And Rev-derived epitopes early after infection. J Virol. 2010; 84: 10907-10912
98. Gillespie GM, Kaul R, Dong T, et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B 7. AIDS. 2002; 16: 961-972
99. Yu XG, Lichterfeld M, Chetty S, et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-Amino-Acid difference between HLA class I subtypes. J Virol. 2007; 81: 1619-1631